Today, India is the world’s largest producer of milk, pulses, and spices; the largest exporter of rice; and among the leading producers of ...

One of the biggest advantages of a group policy is the waiver of the maternity waiting period. In individual policies, maternity typically ...

India's economy shows a strong foundation with 7.7 percent GDP growth for fiscal 2025-26. Prime Minister Narendra Modi stated India is the ...

India is updating its Index of Industrial Production. The new series will use 2022-23 as the base year, replacing the old 2011-12 base. Thi...

Russia and the Taliban have signed a significant military cooperation agreement. This pact alters regional security dynamics. Pakistan's st...

India's National Family Health Survey-6 shows significant improvements in maternal and child health. Vaccinations and antenatal care have i...

Government spending on healthcare has surged to Rs 3.85 lakh crore in 2022-23, nearly tripling from a decade ago. This increased public inv...

Quad foreign ministers met in Delhi focusing on practical cooperation. New initiatives target critical minerals, maritime surveillance, and...

Bernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

Bill Cassidy Louisiana primary election results: Republican Senator's vote in favor of convicting Donald Trump after his 2021 impeachment o...

Ohio voters have chosen their candidates for key November elections. Billionaire Vivek Ramaswamy will face Dr. Amy Acton for governor. Sena...

Moderna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...

Moderna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

Prime Minister Keir Starmer announced AstraZeneca will invest 300 million pounds in UK life sciences. This significant investment secures 1...

Kushal Pal Singh, DLF chairman emeritus, urges India to adopt a bold, long-term urbanisation strategy. He believes radical reforms are vita...